|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
33.100 0.000 (0.000%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.17
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2021 | EPS | 185.00 RMB (cts) | |
| Net Profit | 4,735.27 RMB (MIL) | DPS | 56.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2022 | 5,208.83 | 203.00 | 60.00 | -- | 5,585.00 | 3,736.00 |
| 2023 | 6,221.00 | 243.00 | 73.00 | -- | 6,736.00 | 4,182.00 |
| 2024 | 6,741.70 | 263.50 | 60.90 | -- | 7,964.00 | 5,203.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2022 | 5,394.00 | 210.00 | 63.00 | HSBC | Buy | 70.00 | 13/10/2021 | |
| 2022 | 3,736.00 | 145.80 | 43.70 | CITIGROUP | Buy | 60.00 | 27/04/2022 | |
| 2022 | 4,845.00 | 189.00 | 60.00 | CLSA | Buy | 49.80 | 27/04/2022 | |
| 2022 | 5,585.00 | 218.00 | -- | ICBC INT'L SEC | OutPerform | 42.10 | 05/05/2022 | |
| 2022 | 4,557.80 | 178.00 | 39.00 | CREDIT SUISSE | OutPerform | 40.00 | 27/04/2022 | |
| 2022 | 5,208.83 | 203.00 | -- | MORGAN STANLEY | Equal-weight | 35.00 | 16/03/2022 | |
| 2023 | 6,221.00 | 243.00 | 73.00 | HSBC | -- | -- | 13/10/2021 | |
| 2023 | 4,182.00 | 163.20 | 49.00 | CITIGROUP | -- | -- | 27/04/2022 | |
| 2023 | 6,736.00 | 263.00 | 80.00 | CLSA | -- | -- | 27/04/2022 | |
| 2023 | 6,542.00 | 255.00 | -- | ICBC INT'L SEC | -- | -- | 05/05/2022 | |
| 2023 | 5,677.10 | 222.00 | 52.93 | CREDIT SUISSE | -- | -- | 27/04/2022 | |
| 2023 | 5,988.15 | 234.00 | -- | MORGAN STANLEY | -- | -- | 16/03/2022 | |
| 2024 | 5,203.00 | 203.00 | 60.90 | CITIGROUP | -- | -- | 27/04/2022 | |
| 2024 | 7,964.00 | 311.00 | 90.00 | CLSA | -- | -- | 27/04/2022 | |
| 2024 | 7,574.00 | 296.00 | -- | ICBC INT'L SEC | -- | -- | 05/05/2022 | |
| 2024 | 5,909.40 | 231.00 | 55.72 | CREDIT SUISSE | -- | -- | 27/04/2022 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 17/05/2022 08:54 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,735,270 |
| %Change | 29.280% |
| EPS / (LPS) | RMB 1.850 |
| NBV Per Share (¥) | RMB 15.270 |